Advertisement

Topics

BMG Pharma is Pleased to Announce Positive Clinical Results on GelX® the First Breakthrough Product to Achieve Prevention of Oral Mucositis in Cancer Patients

08:00 EST 15 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the first efficacy data on its GelX® product for the prevention of oral mucositis. The new clinical data, (conducted under Good ...

Other Sources for this Article

BMG Pharma S.r.l.
Mrs. Loredana Galli
loredana.galli@bmgpharma.com

NEXT ARTICLE

More From BioPortfolio on "BMG Pharma is Pleased to Announce Positive Clinical Results on GelX® the First Breakthrough Product to Achieve Prevention of Oral Mucositis in Cancer Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...